0000950170-24-000407.txt : 20240102 0000950170-24-000407.hdr.sgml : 20240102 20240102184151 ACCESSION NUMBER: 0000950170-24-000407 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grissinger Michael CENTRAL INDEX KEY: 0001757601 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 24503893 MAIL ADDRESS: STREET 1: C/O RESTORBIO, INC. STREET 2: 500 BOYLSTON ST., 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 3 1 ownership.xml 3 X0206 3 2024-01-01 0 0001541157 Akari Therapeutics Plc AKTX 0001757601 Grissinger Michael C/O AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 true false false false Ordinary Shares, par value $0.0001 per share 20000000 D Stock Option (Right to Buy) 0.0347 2022-01-23 2028-01-23 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0208 2019-06-27 2028-09-19 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0207 2020-06-30 2029-06-27 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0218 2021-06-30 2030-06-30 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0173 2022-06-30 2031-06-30 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0100 2023-06-30 2032-06-30 Ordinary Shares, par value $0.0001 per share 1300000 D Stock Option (Right to Buy) 0.0048 2023-06-30 2032-10-21 Ordinary Shares, par value $0.0001 per share 3700000 D Stock Option (Right to Buy) 0.0017 2033-06-30 Ordinary Shares, par value $0.0001 per share 5000000 D Non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan. The stock option vested and became exercisable in four equal installments of twenty-five percent (25%), with the with the first installment vesting on January 23, 2019 and an additional 25% vesting on each annual anniversary of the vesting date thereafter. Non-qualified stock option granted under the Issuer's 2023 Equity Incentive Plan. One-hundred percent (100%) of the stock option vests and becomes exercisable on the date of the Issuer's 2024 Annual General Meeting. See Exhibit 24.1 - Power of Attorney /s/ Rachelle Jacques, as Attorney-in-Fact for Michael Grissinger 2024-01-02 EX-24.1 2 aktx-ex24_1.htm EX-24.1 EX-24.1

Exhibit 24.1

 

 

Power of Attorney

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each and any of Rachelle Jacques and Wendy F. DiCicco his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to:

 

1.
Sign any and all instruments, certificates and documents appropriate or required to be executed on behalf of the undersigned pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any and all regulations promulgated thereunder (including, without limitation, any Joint Filing Agreement with respect thereto), and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission (the “SEC”), and with any other entity when and if such is mandated by the Exchange Act or by the Bylaws of the Financial Industry Regulatory Authority;
1.
prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications thereto) with respect to obtaining EDGAR codes, with the SEC;
2.
seek or obtain, as the representative of the undersigned and on behalf of the undersigned, information on transactions in securities, from any third party, including brokers,employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such attorneys-in-fact and the undersigned approves and ratifies any such release of information; and
3.
perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

1.
this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorneys-in-fact without independent verification of such information;
2.
any documents prepared and/or executed by such attorneys-in-fact on behalf of any of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his/her discretion, deems necessary or desirable;
3.
the attorneys-in-fact do not assume (a) any liability for responsibility to comply with the requirements of the Exchange Act for any of the undersigned, (b) any liability for any failure to comply with such requirements for any of the undersigned, or (c) any obligation or liability for profit disgorgement under Section 16(b) of the Exchange Act for any of the undersigned; and
4.
this Power of Attorney does not relieve any of the undersigned from responsibility for compliance with the undersigned’s obligations under the Exchange Act, including without limitation the reporting requirements under Sections 13 and 16 of the Exchange Act.

 

The undersigned hereby gives and grants the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, with full power of substitution and revocation, hereby ratifying all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Power of Attorney. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorneys-in-fact.

 

[Signature page follows]

 


 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of December, 2023.

 

 /s/ Michael Grissinger

 

Michael Grissinger